CIK 0000727510 · Non-accelerated filer<br>Smaller reporting company
Viskase Holdings, Inc.
Sign in to watch- Ticker
- VISK
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 222372868
- Phone
- (630) 874-0700
- Business address
- 333 EAST BUTTERFIELD ROAD, SUITE 400, LOMBARD, IL, 60148
- Former names
- ENZON PHARMACEUTICALS, INC., ENZON PHARMACEUTICALS INC, ENZON PHARMACEUTICALS INC, ENZON PHARMACEUTICAL INC, ENZON INC
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Director sold 55,926 shares at an average $1.72 ($96,082)
- 4 Grant or award VP and General Counsel acquired 4,686 shares (grant or award)
- 4 Grant or award VP, Clinical Development acquired 3,748 shares (grant or award)
- 4 Grant or award SVP, R&D Program Management acquired 2,343 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Interim PEO and Interim COO acquired 24,500 shares (grant or award)
- 4 Open-market sale Director sold 5,820 shares at $6.58 ($38,308)
- 4 Open-market sale Director sold 1,933 shares at $6.58 ($12,720)
- 4 Grant or award Director acquired 10,669 shares (grant or award)
- 4 Grant or award Director acquired 10,669 shares (grant or award)
- 4 Grant or award Director acquired 10,669 shares (grant or award)
- 4 Grant or award Director acquired 10,669 shares (grant or award)
- 4 Grant or award Director acquired 18,670 shares (grant or award)
- 4 Grant or award Director acquired 21,338 shares (grant or award)
Page 3 of 28 · 560 filings